Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses for vascular access in Korean patients on hemodialysis. Methods: This was a descriptive observational study. We inspected the insurance claims of patients with chronic kidney disease who underwent hemodialysis between January 2008 and December 2016. We calculated descriptive statistics of the frequencies and medical expenses of procedures for vascular access. Results: The national medical expenses for access-related treatment were 7.12 billion KRW (equivalent to 6.36 million USD) in 2008, and these expenses increased to 42.12 billion KRW (equivalent to 37.67 million USD) in 2016. The population of hemodialysis patients, the annual frequency of access-related procedures, and the total medical cost for access-related procedures increased by 1.6-, 2.6-, and 5.9-fold, respectively, over the past 9 years. The frequency and costs of access care increased as the number of patients on hemodialysis increased. The increase in vascular access-related costs has largely been driven by increased numbers of percutaneous angioplasty. Conclusions: The increasing proportion of medical costs for percutaneous angioplasty represents a challenge in the management of end-stage renal disease in Korea. It is essential to identify the clinical and physiological aspects as well as anatomical abnormalities before planning angioplasty. A timely surgical correction could be a viable option to control the rapid growth of access-related medical expenses.
Abstract
Background/Aims: The Republic of Korea is a country where the hemodialysis population is growing rapidly. It is believed that the numbers of treatments related to vascular access-related complications are also increasing. This study investigated the current status of treatment and medical expenses for vascular access in Korean patients on hemodialysis. Methods: This was a descriptive observational study. We inspected the insurance claims of patients with chronic kidney disease who underwent hemodialysis between January 2008 and December 2016. We calculated descriptive statistics of the frequencies and medical expenses of procedures for vascular access. Results: The national medical expenses for access-related treatment were 7.12 billion KRW (equivalent to 6.36 million USD) in 2008, and these expenses increased to 42.12 billion KRW (equivalent to 37.67 million USD) in 2016. The population of hemodialysis patients, the annual frequency of access-related procedures, and the total medical cost for access-related procedures increased by 1.6-, 2.6-, and 5.9-fold, respectively, over the past 9 years. The frequency and costs of access care increased as the number of patients on hemodialysis increased. The increase in vascular access-related costs has largely been driven by increased numbers of percutaneous angioplasty. Conclusions: The increasing proportion of medical costs for percutaneous angioplasty represents a challenge in the management of end-stage renal disease in Korea. It is essential to identify the clinical and physiological aspects as well as anatomical abnormalities before planning angioplasty. A timely surgical correction could be a viable option to control the rapid growth of access-related medical expenses.
참고문헌 (15)
- 진동찬, "우리나라 말기신부전 환자의 투석현황", 대한의사협회지, 56(7), pp.562~568 (2013), 대한의사협회
- "National Health Insurance Program in Korea" (2010)[URL]
- "Korean Standard Statistical Classification of Disease" (1996)[URL]
- "Outcomes research of peritoneal dialysis and hemodialysis for end-stage renal disease" (2017)[URL]
- National Health Insurance Service, "National Health Insurance Statistical Yearbook" (2017), National Health Insurance Service
- 2017 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, "United States Renal Data System", National Institutes of Health, ~ (2017)
- Takemoto Y, "The economic issue of vascular access within the Japanese medical reimbursement system", J Vasc Access, 16(Suppl 10), pp.S9~S12 (2015)
- National Kidney Foundation, "NKF-KDOQI clinical practice guidelines for vascular access", Am J Kidney Dis, 48(Suppl 1), pp.S176~S276 (2006)
- Dember LM, "Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis", Kidney Int, 66, pp.390~398 (2004)
- Moist LM, "Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival", J Am Soc Nephrol, 14, pp.2645~2653 (2003)
- Ravani P, "Preemptive correction of arteriovenous access stenosis: a systematic review and meta-analysis of randomized controlled trials", Am J Kidney Dis, 67, pp.446~460 (2016)
- Argyriou C, "Preemptive open surgical vs. endovascular repair for juxta-anastomotic stenoses of autogenous AV fistulae: a meta-analysis", J Vasc Access, 16, pp.454~458 (2015)
- Sigala F, "Surgical treatment of cephalic arch stenosis by central transposition of the cephalic vein", J Vasc Access, 15, pp.272~277 (2014)
- National Kidney Foundation, "NKF-KDOQI clinical practice guidelines for vascular access. Guideline 29: goals of access placement maximizing primary AV fistulae", Am J Kidney Dis, 37(Suppl 1), pp.S169~ (2001)
- "Korean ESRD Registry 2018" (2016)[URL]